Universität Wien FIND
Warning! The directory is not yet complete and will be amended until the beginning of the term.

323005 VO Preclinical Drug Development - MPS4 (2021W)

7.00 ECTS (3.00 SWS), SPL 32 - Pharmazie

10.01.2022 14.00-17.00
11.01.2022 14.00-17.00
12.01.2022 14.00-17.00
13.01.2022 14.00-17.00
14.01.2022 14.00-17.00
17.01.2022 14.00-17.00
18.01.2022 14.00-17.00
19.01.2022 14.00-17.00
20.01.2022 14.00-17.00

27.01.2022 14.00-15.30 ONLINE
25.02.2022 09.00-10.30 ONLINE
11.03.2022 09.00-10.30 ONLINE


Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).


Language: English

Examination dates



MPS4 will take place in January 2022, after the successful graduation of MPS1, MPS2 and MPS3.
10.01.; 11.01.; 12.01.; 13.01.; 14.01.; 17.01.; 18.01.; 19.01.; 20.01. 2-5 pm


Aims, contents and method of the course

The students will be introduced to basic principles in preclinical drug development, consisting of three maintopics: Preclinical profiling, ADMET basic principles and synthetic methods in medicinal chemistry. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by discussions rounds.

Assessment and permitted materials

There will be one oral evaluation at the end of the course. The grades will be deduced from the result in the oral evaluation.

Minimum requirements and assessment criteria

minimum 60% to pass

Examination topics

All topics covered during the course as well as the provided material on the moodle platform for MPS4.

Reading list

Association in the course directory

Last modified: Tu 19.10.2021 08:49